- News & Analysis
- Home
- Latest News
- Reports
- Podcasts
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Sectors
Revolut receives $800m at $33bn valuation
SoftBank Vision Fund 2 and Tiger Global Management provided the cash, increasing the mobile financial services provider's overall funding to over $1.7bn.
Jul 16, 2021Paytm prepares $2.2bn initial public offering
The corporate-backed mobile payments app’s parent company, One97 Communications, has filed to float in an offering set to include $1.1bn of existing share sales.
Jul 16, 2021MS&AD Ventures boosts fund to $200m
MS&AD Holdings has put up an additional $80m for its corporate venture capital vehicle, two years after tripling its original commitment.
Jul 16, 2021Imperative Care imports $260m in series D
Imperative Care boosted its total funding to at least $379m, with Ascension Ventures participating in the stroke care technology provider's series D round.
Jul 16, 2021Restar readies corporate venturing initiative
The semiconductor contract manufacturer’s Restar-SBI Innovation fund will focus on developers of digitalisation and healthcare technologies.
Jul 16, 2021Imago BioSciences bags $134m in upsized IPO
Pharmaron, Celgene, Amgen and Merck & Co-backed Imago BioSciences floated in an IPO today, alongside a private placement transaction featuring Pfizer.
Jul 16, 2021Wugen wraps up $172m series B
Alexandria Venture Investments was among the participants in a series B round for Wugen, which is developing cellular therapeutics for cancer.
Jul 16, 2021Netradyne accelerates to $150m series C
SoftBank Vision Fund 2 led a series C round for the driver safety technology developer at a valuation of almost $1bn that also featured M12.
Jul 16, 2021FedEx Express injects $100m in Delhivery
FedEx Express has provided the shipping and logistics service provider with fresh funding which will boost its pick-up and delivery services across India.
Jul 16, 2021Kriya Therapeutics engineers $100m series B
Patient Square Capital led a series B round for the gene therapy developer that included existing corporate investor Dexcel Pharma.
Jul 16, 2021Railsbank sails to $70m
Bank Central Asia’s Central Capital Ventura unit and Cohen and Company were among the investors in the banking software provider’s latest round.
Jul 16, 2021Mann takes on Takeda Ventures role
Takeda Ventures has brought on Mann as a senior partner who draws on extensive life sciences-focused venture capital experience.
Jul 16, 2021Featured Content
GCVI Summit 2026 RewindRewatch the sessions, recap the learningsGCVI Summit 2026 Rewind
Rewatch the sessions, recap the learnings
The World of Corporate VenturingGCV's annual report on the state of the corporate investment sectorThe World of Corporate Venturing
GCV's annual report on the state of the corporate investment sector
GCV’s Rising Stars and Emerging Leaders 2026The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.GCV’s Rising Stars and Emerging Leaders 2026
The talent pipeline in corporate venturing shows both momentum and staying power, as the industry comes of age.
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation


